Formulation, Development & Delivery In-Depth Focus 2019
Posted: 29 August 2019 | European Pharmaceutical Review | No comments yet
This In-Depth Focus investigates anticancer nanomedicine developments and the future of MALDI imaging for pharmaceutical formulation research.
- Mahfoozur Rahman and Sarwar Beg explain why we need to change tack from traditional formulation-driven development to a refined target-based approach in order to increase success with anticancer nanomedicine in the clinic.
- Dr Carsten Hopf and his team are using MALDI imaging in several applications, including drug metabolite and formulation distributions in tissues. This article investigates how this content-rich technique is enabling researchers to gain unique insights to facilitate faster and better drug discovery and improve the future of pharmaceutical formulation research.
Issue
Related topics
Drug Delivery Systems, Drug Development, Drug Manufacturing, Formulation, QA/QC, Research & Development (R&D)
Related organisations
Bruker Daltonics, Jamia Hamdard (Hamdard University), Mannheim Technical University, Sam Higginbottom University of Agriculture Technology & Sciences
Related people
Dr Carsten Hopf, Dr Rohan Thakur, Dr Sarwar Beg, Mahfoozur Rahman